TNF or EGFR inhibition equally block AKI-to-CKD transition: opportunities for etanercept treatment.
Mai M AbdelmageedEirini KefaloyianniAkshayakeerthi ArthanarisamiYohei KomaruJeffrey J AtkinsonAndreas HerrlichPublished in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2022)
Short-term anti-TNF biologics during or after AKI could be helpful in the prevention of AKI-to-CKD transition.